| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |